0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intracranial Drug Eluting Stents Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-24G9384
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Intracranial Drug Eluting Stents Market Research Report 2022
BUY CHAPTERS

Global Intracranial Drug Eluting Stents Market Research Report 2025

Code: QYRE-Auto-24G9384
Report
March 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intracranial Drug Eluting Stents Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intracranial Drug Eluting Stents Market

Intracranial Drug Eluting Stents Market

The global market for Intracranial Drug Eluting Stents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intracranial Drug Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Drug Eluting Stents.
The Intracranial Drug Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intracranial Drug Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Drug Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intracranial Drug Eluting Stents Market Report

Report Metric Details
Report Name Intracranial Drug Eluting Stents Market
CAGR 5%
Segment by Type
  • Cobalt-chromium Alloy Stents
  • Magnesium Alloy Stents
  • Stainless Steel Stents
  • Others
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik, Blue Medical, DISA Vascular, Essen, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, TEDA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intracranial Drug Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intracranial Drug Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Intracranial Drug Eluting Stents Market report?

Ans: The main players in the Intracranial Drug Eluting Stents Market are Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik, Blue Medical, DISA Vascular, Essen, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, TEDA

What are the Application segmentation covered in the Intracranial Drug Eluting Stents Market report?

Ans: The Applications covered in the Intracranial Drug Eluting Stents Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Intracranial Drug Eluting Stents Market report?

Ans: The Types covered in the Intracranial Drug Eluting Stents Market report are Cobalt-chromium Alloy Stents, Magnesium Alloy Stents, Stainless Steel Stents, Others

1 Intracranial Drug Eluting Stents Market Overview
1.1 Product Definition
1.2 Intracranial Drug Eluting Stents by Type
1.2.1 Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Stainless Steel Stents
1.2.5 Others
1.3 Intracranial Drug Eluting Stents by Application
1.3.1 Global Intracranial Drug Eluting Stents Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intracranial Drug Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Intracranial Drug Eluting Stents Revenue 2020-2031
1.4.2 Global Intracranial Drug Eluting Stents Sales 2020-2031
1.4.3 Global Intracranial Drug Eluting Stents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intracranial Drug Eluting Stents Market Competition by Manufacturers
2.1 Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intracranial Drug Eluting Stents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intracranial Drug Eluting Stents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intracranial Drug Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intracranial Drug Eluting Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intracranial Drug Eluting Stents, Product Type & Application
2.7 Global Key Manufacturers of Intracranial Drug Eluting Stents, Date of Enter into This Industry
2.8 Global Intracranial Drug Eluting Stents Market Competitive Situation and Trends
2.8.1 Global Intracranial Drug Eluting Stents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intracranial Drug Eluting Stents Players Market Share by Revenue
2.8.3 Global Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intracranial Drug Eluting Stents Market Scenario by Region
3.1 Global Intracranial Drug Eluting Stents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intracranial Drug Eluting Stents Sales by Region: 2020-2031
3.2.1 Global Intracranial Drug Eluting Stents Sales by Region: 2020-2025
3.2.2 Global Intracranial Drug Eluting Stents Sales by Region: 2026-2031
3.3 Global Intracranial Drug Eluting Stents Revenue by Region: 2020-2031
3.3.1 Global Intracranial Drug Eluting Stents Revenue by Region: 2020-2025
3.3.2 Global Intracranial Drug Eluting Stents Revenue by Region: 2026-2031
3.4 North America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.4.1 North America Intracranial Drug Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intracranial Drug Eluting Stents Sales by Country (2020-2031)
3.4.3 North America Intracranial Drug Eluting Stents Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.5.1 Europe Intracranial Drug Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intracranial Drug Eluting Stents Sales by Country (2020-2031)
3.5.3 Europe Intracranial Drug Eluting Stents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intracranial Drug Eluting Stents Market Facts & Figures by Region
3.6.1 Asia Pacific Intracranial Drug Eluting Stents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2020-2031)
3.6.3 Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.7.1 Latin America Intracranial Drug Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intracranial Drug Eluting Stents Sales by Country (2020-2031)
3.7.3 Latin America Intracranial Drug Eluting Stents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Intracranial Drug Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intracranial Drug Eluting Stents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intracranial Drug Eluting Stents Sales by Type (2020-2031)
4.1.1 Global Intracranial Drug Eluting Stents Sales by Type (2020-2025)
4.1.2 Global Intracranial Drug Eluting Stents Sales by Type (2026-2031)
4.1.3 Global Intracranial Drug Eluting Stents Sales Market Share by Type (2020-2031)
4.2 Global Intracranial Drug Eluting Stents Revenue by Type (2020-2031)
4.2.1 Global Intracranial Drug Eluting Stents Revenue by Type (2020-2025)
4.2.2 Global Intracranial Drug Eluting Stents Revenue by Type (2026-2031)
4.2.3 Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2020-2031)
4.3 Global Intracranial Drug Eluting Stents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intracranial Drug Eluting Stents Sales by Application (2020-2031)
5.1.1 Global Intracranial Drug Eluting Stents Sales by Application (2020-2025)
5.1.2 Global Intracranial Drug Eluting Stents Sales by Application (2026-2031)
5.1.3 Global Intracranial Drug Eluting Stents Sales Market Share by Application (2020-2031)
5.2 Global Intracranial Drug Eluting Stents Revenue by Application (2020-2031)
5.2.1 Global Intracranial Drug Eluting Stents Revenue by Application (2020-2025)
5.2.2 Global Intracranial Drug Eluting Stents Revenue by Application (2026-2031)
5.2.3 Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2020-2031)
5.3 Global Intracranial Drug Eluting Stents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Intracranial Drug Eluting Stents Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic Vascular
6.2.1 Medtronic Vascular Company Information
6.2.2 Medtronic Vascular Description and Business Overview
6.2.3 Medtronic Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Vascular Intracranial Drug Eluting Stents Product Portfolio
6.2.5 Medtronic Vascular Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Company Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Advantec Vascular Intracranial Drug Eluting Stents Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B.Braun Melsengen
6.4.1 B.Braun Melsengen Company Information
6.4.2 B.Braun Melsengen Description and Business Overview
6.4.3 B.Braun Melsengen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B.Braun Melsengen Intracranial Drug Eluting Stents Product Portfolio
6.4.5 B.Braun Melsengen Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Company Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Intracranial Drug Eluting Stents Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Terumo Medical
6.6.1 Terumo Medical Company Information
6.6.2 Terumo Medical Description and Business Overview
6.6.3 Terumo Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Medical Intracranial Drug Eluting Stents Product Portfolio
6.6.5 Terumo Medical Recent Developments/Updates
6.7 Biosensors
6.7.1 Biosensors Company Information
6.7.2 Biosensors Description and Business Overview
6.7.3 Biosensors Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biosensors Intracranial Drug Eluting Stents Product Portfolio
6.7.5 Biosensors Recent Developments/Updates
6.8 Biotronik
6.8.1 Biotronik Company Information
6.8.2 Biotronik Description and Business Overview
6.8.3 Biotronik Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biotronik Intracranial Drug Eluting Stents Product Portfolio
6.8.5 Biotronik Recent Developments/Updates
6.9 Blue Medical
6.9.1 Blue Medical Company Information
6.9.2 Blue Medical Description and Business Overview
6.9.3 Blue Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Blue Medical Intracranial Drug Eluting Stents Product Portfolio
6.9.5 Blue Medical Recent Developments/Updates
6.10 DISA Vascular
6.10.1 DISA Vascular Company Information
6.10.2 DISA Vascular Description and Business Overview
6.10.3 DISA Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DISA Vascular Intracranial Drug Eluting Stents Product Portfolio
6.10.5 DISA Vascular Recent Developments/Updates
6.11 Essen
6.11.1 Essen Company Information
6.11.2 Essen Description and Business Overview
6.11.3 Essen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Essen Intracranial Drug Eluting Stents Product Portfolio
6.11.5 Essen Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Company Information
6.12.2 MicroPort Medical Description and Business Overview
6.12.3 MicroPort Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MicroPort Medical Intracranial Drug Eluting Stents Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Company Information
6.13.2 MIV Therapeutics Description and Business Overview
6.13.3 MIV Therapeutics Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MIV Therapeutics Intracranial Drug Eluting Stents Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Company Information
6.14.2 Orbusneich Description and Business Overview
6.14.3 Orbusneich Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Orbusneich Intracranial Drug Eluting Stents Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Promed Medical
6.15.1 Promed Medical Company Information
6.15.2 Promed Medical Description and Business Overview
6.15.3 Promed Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Promed Medical Intracranial Drug Eluting Stents Product Portfolio
6.15.5 Promed Medical Recent Developments/Updates
6.16 Relisys Medical
6.16.1 Relisys Medical Company Information
6.16.2 Relisys Medical Description and Business Overview
6.16.3 Relisys Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Relisys Medical Intracranial Drug Eluting Stents Product Portfolio
6.16.5 Relisys Medical Recent Developments/Updates
6.17 Reva Medical
6.17.1 Reva Medical Company Information
6.17.2 Reva Medical Description and Business Overview
6.17.3 Reva Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Reva Medical Intracranial Drug Eluting Stents Product Portfolio
6.17.5 Reva Medical Recent Developments/Updates
6.18 Sahajanand
6.18.1 Sahajanand Company Information
6.18.2 Sahajanand Description and Business Overview
6.18.3 Sahajanand Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sahajanand Intracranial Drug Eluting Stents Product Portfolio
6.18.5 Sahajanand Recent Developments/Updates
6.19 Sino Medical
6.19.1 Sino Medical Company Information
6.19.2 Sino Medical Description and Business Overview
6.19.3 Sino Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Sino Medical Intracranial Drug Eluting Stents Product Portfolio
6.19.5 Sino Medical Recent Developments/Updates
6.20 Sorin
6.20.1 Sorin Company Information
6.20.2 Sorin Description and Business Overview
6.20.3 Sorin Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Sorin Intracranial Drug Eluting Stents Product Portfolio
6.20.5 Sorin Recent Developments/Updates
6.21 TEDA
6.21.1 TEDA Company Information
6.21.2 TEDA Description and Business Overview
6.21.3 TEDA Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.21.4 TEDA Intracranial Drug Eluting Stents Product Portfolio
6.21.5 TEDA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intracranial Drug Eluting Stents Industry Chain Analysis
7.2 Intracranial Drug Eluting Stents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intracranial Drug Eluting Stents Production Mode & Process Analysis
7.4 Intracranial Drug Eluting Stents Sales and Marketing
7.4.1 Intracranial Drug Eluting Stents Sales Channels
7.4.2 Intracranial Drug Eluting Stents Distributors
7.5 Intracranial Drug Eluting Stents Customer Analysis
8 Intracranial Drug Eluting Stents Market Dynamics
8.1 Intracranial Drug Eluting Stents Industry Trends
8.2 Intracranial Drug Eluting Stents Market Drivers
8.3 Intracranial Drug Eluting Stents Market Challenges
8.4 Intracranial Drug Eluting Stents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intracranial Drug Eluting Stents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intracranial Drug Eluting Stents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intracranial Drug Eluting Stents Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intracranial Drug Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intracranial Drug Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intracranial Drug Eluting Stents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intracranial Drug Eluting Stents, Product Type & Application
 Table 12. Global Key Manufacturers of Intracranial Drug Eluting Stents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intracranial Drug Eluting Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Drug Eluting Stents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intracranial Drug Eluting Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intracranial Drug Eluting Stents Sales by Region (2020-2025) & (Units)
 Table 18. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2020-2025)
 Table 19. Global Intracranial Drug Eluting Stents Sales by Region (2026-2031) & (Units)
 Table 20. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2026-2031)
 Table 21. Global Intracranial Drug Eluting Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2020-2025)
 Table 23. Global Intracranial Drug Eluting Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2026-2031)
 Table 25. North America Intracranial Drug Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intracranial Drug Eluting Stents Sales by Country (2020-2025) & (Units)
 Table 27. North America Intracranial Drug Eluting Stents Sales by Country (2026-2031) & (Units)
 Table 28. North America Intracranial Drug Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intracranial Drug Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intracranial Drug Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intracranial Drug Eluting Stents Sales by Country (2020-2025) & (Units)
 Table 32. Europe Intracranial Drug Eluting Stents Sales by Country (2026-2031) & (Units)
 Table 33. Europe Intracranial Drug Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intracranial Drug Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intracranial Drug Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intracranial Drug Eluting Stents Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Intracranial Drug Eluting Stents Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Intracranial Drug Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intracranial Drug Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intracranial Drug Eluting Stents Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Intracranial Drug Eluting Stents Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intracranial Drug Eluting Stents Sales (Units) by Type (2020-2025)
 Table 51. Global Intracranial Drug Eluting Stents Sales (Units) by Type (2026-2031)
 Table 52. Global Intracranial Drug Eluting Stents Sales Market Share by Type (2020-2025)
 Table 53. Global Intracranial Drug Eluting Stents Sales Market Share by Type (2026-2031)
 Table 54. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2020-2025)
 Table 57. Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2026-2031)
 Table 58. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intracranial Drug Eluting Stents Sales (Units) by Application (2020-2025)
 Table 61. Global Intracranial Drug Eluting Stents Sales (Units) by Application (2026-2031)
 Table 62. Global Intracranial Drug Eluting Stents Sales Market Share by Application (2020-2025)
 Table 63. Global Intracranial Drug Eluting Stents Sales Market Share by Application (2026-2031)
 Table 64. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2020-2025)
 Table 67. Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2026-2031)
 Table 68. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Intracranial Drug Eluting Stents Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Medtronic Vascular Company Information
 Table 76. Medtronic Vascular Description and Business Overview
 Table 77. Medtronic Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Vascular Intracranial Drug Eluting Stents Product
 Table 79. Medtronic Vascular Recent Developments/Updates
 Table 80. Advantec Vascular Company Information
 Table 81. Advantec Vascular Description and Business Overview
 Table 82. Advantec Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Advantec Vascular Intracranial Drug Eluting Stents Product
 Table 84. Advantec Vascular Recent Developments/Updates
 Table 85. B.Braun Melsengen Company Information
 Table 86. B.Braun Melsengen Description and Business Overview
 Table 87. B.Braun Melsengen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. B.Braun Melsengen Intracranial Drug Eluting Stents Product
 Table 89. B.Braun Melsengen Recent Developments/Updates
 Table 90. Boston Scientific Company Information
 Table 91. Boston Scientific Description and Business Overview
 Table 92. Boston Scientific Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Boston Scientific Intracranial Drug Eluting Stents Product
 Table 94. Boston Scientific Recent Developments/Updates
 Table 95. Terumo Medical Company Information
 Table 96. Terumo Medical Description and Business Overview
 Table 97. Terumo Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Terumo Medical Intracranial Drug Eluting Stents Product
 Table 99. Terumo Medical Recent Developments/Updates
 Table 100. Biosensors Company Information
 Table 101. Biosensors Description and Business Overview
 Table 102. Biosensors Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biosensors Intracranial Drug Eluting Stents Product
 Table 104. Biosensors Recent Developments/Updates
 Table 105. Biotronik Company Information
 Table 106. Biotronik Description and Business Overview
 Table 107. Biotronik Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biotronik Intracranial Drug Eluting Stents Product
 Table 109. Biotronik Recent Developments/Updates
 Table 110. Blue Medical Company Information
 Table 111. Blue Medical Description and Business Overview
 Table 112. Blue Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Blue Medical Intracranial Drug Eluting Stents Product
 Table 114. Blue Medical Recent Developments/Updates
 Table 115. DISA Vascular Company Information
 Table 116. DISA Vascular Description and Business Overview
 Table 117. DISA Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. DISA Vascular Intracranial Drug Eluting Stents Product
 Table 119. DISA Vascular Recent Developments/Updates
 Table 120. Essen Company Information
 Table 121. Essen Description and Business Overview
 Table 122. Essen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Essen Intracranial Drug Eluting Stents Product
 Table 124. Essen Recent Developments/Updates
 Table 125. MicroPort Medical Company Information
 Table 126. MicroPort Medical Description and Business Overview
 Table 127. MicroPort Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. MicroPort Medical Intracranial Drug Eluting Stents Product
 Table 129. MicroPort Medical Recent Developments/Updates
 Table 130. MIV Therapeutics Company Information
 Table 131. MIV Therapeutics Description and Business Overview
 Table 132. MIV Therapeutics Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. MIV Therapeutics Intracranial Drug Eluting Stents Product
 Table 134. MIV Therapeutics Recent Developments/Updates
 Table 135. Orbusneich Company Information
 Table 136. Orbusneich Description and Business Overview
 Table 137. Orbusneich Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Orbusneich Intracranial Drug Eluting Stents Product
 Table 139. Orbusneich Recent Developments/Updates
 Table 140. Promed Medical Company Information
 Table 141. Promed Medical Description and Business Overview
 Table 142. Promed Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Promed Medical Intracranial Drug Eluting Stents Product
 Table 144. Promed Medical Recent Developments/Updates
 Table 145. Relisys Medical Company Information
 Table 146. Relisys Medical Description and Business Overview
 Table 147. Relisys Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Relisys Medical Intracranial Drug Eluting Stents Product
 Table 149. Relisys Medical Recent Developments/Updates
 Table 150. Reva Medical Company Information
 Table 151. Reva Medical Description and Business Overview
 Table 152. Reva Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Reva Medical Intracranial Drug Eluting Stents Product
 Table 154. Reva Medical Recent Developments/Updates
 Table 155. Sahajanand Company Information
 Table 156. Sahajanand Description and Business Overview
 Table 157. Sahajanand Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Sahajanand Intracranial Drug Eluting Stents Product
 Table 159. Sahajanand Recent Developments/Updates
 Table 160. Sino Medical Company Information
 Table 161. Sino Medical Description and Business Overview
 Table 162. Sino Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Sino Medical Intracranial Drug Eluting Stents Product
 Table 164. Sino Medical Recent Developments/Updates
 Table 165. Sorin Company Information
 Table 166. Sorin Description and Business Overview
 Table 167. Sorin Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Sorin Intracranial Drug Eluting Stents Product
 Table 169. Sorin Recent Developments/Updates
 Table 170. TEDA Company Information
 Table 171. TEDA Description and Business Overview
 Table 172. TEDA Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. TEDA Intracranial Drug Eluting Stents Product
 Table 174. TEDA Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Intracranial Drug Eluting Stents Distributors List
 Table 178. Intracranial Drug Eluting Stents Customers List
 Table 179. Intracranial Drug Eluting Stents Market Trends
 Table 180. Intracranial Drug Eluting Stents Market Drivers
 Table 181. Intracranial Drug Eluting Stents Market Challenges
 Table 182. Intracranial Drug Eluting Stents Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intracranial Drug Eluting Stents
 Figure 2. Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intracranial Drug Eluting Stents Market Share by Type: 2024 & 2031
 Figure 4. Cobalt-chromium Alloy Stents Product Picture
 Figure 5. Magnesium Alloy Stents Product Picture
 Figure 6. Stainless Steel Stents Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Intracranial Drug Eluting Stents Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Intracranial Drug Eluting Stents Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Specialty Clinic
 Figure 12. Others
 Figure 13. Global Intracranial Drug Eluting Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Intracranial Drug Eluting Stents Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Intracranial Drug Eluting Stents Sales (2020-2031) & (Units)
 Figure 16. Global Intracranial Drug Eluting Stents Average Price (US$/Unit) & (2020-2031)
 Figure 17. Intracranial Drug Eluting Stents Report Years Considered
 Figure 18. Intracranial Drug Eluting Stents Sales Share by Manufacturers in 2024
 Figure 19. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Intracranial Drug Eluting Stents Players: Market Share by Revenue in Intracranial Drug Eluting Stents in 2024
 Figure 21. Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Intracranial Drug Eluting Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Intracranial Drug Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 24. North America Intracranial Drug Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Intracranial Drug Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 28. Europe Intracranial Drug Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Intracranial Drug Eluting Stents Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Intracranial Drug Eluting Stents Revenue Market Share by Region (2020-2031)
 Figure 36. China Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Intracranial Drug Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Intracranial Drug Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Intracranial Drug Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Intracranial Drug Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Intracranial Drug Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Intracranial Drug Eluting Stents by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Intracranial Drug Eluting Stents by Type (2020-2031)
 Figure 58. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Intracranial Drug Eluting Stents by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Intracranial Drug Eluting Stents by Application (2020-2031)
 Figure 61. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2020-2031)
 Figure 62. Intracranial Drug Eluting Stents Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Embolization Particle Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-33P8693
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Invasive Blood Pressure Transducer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8B18422
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Invasive Blood Pressure Transducer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30A17966
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Home Automated External Defibrillator Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10Y19630
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

OSZAR »